Mallinckrodt Plc (NYSE:MNK)

3.41
Delayed Data
As of Dec 06
 +0.03 / +0.89%
Today’s Change
1.43
Today|||52-Week Range
27.33
-78.42%
Year-to-Date
No recent news for Mallinckrodt Plc.

Today’s Trading

Previous close3.38
Today’s open3.49
Day’s range3.35 - 3.53
Volume4,094,966
Average volume (3 months)9,394,985
Market cap$286.8M
Data as of 6:30pm ET, 12/06/2019

Growth & Valuation

Earnings growth (last year)-336.68%
Earnings growth (this year)+7.39%
Earnings growth (next 5 years)-10.50%
Revenue growth (last year)-0.19%
P/E ratioNM
Price/Sales0.42
Price/Book0.10

Competitors

 Today’s
change
Today’s
% change
CTMXCytomX Therapeutics ...+0.16+2.61%
FULCFulcrum Therapeutics...+1.21+11.04%
PBYIPuma Biotechnology I...+0.44+5.91%
ALBOAlbireo Pharma Inc-0.59-2.76%
Data as of 4:00pm ET, 12/06/2019

Financials

Next reporting dateFebruary 25, 2020
EPS forecast (this quarter)$2.06
Annual revenue (last year)$3.2B
Annual profit (last year)-$3.6B
Net profit margin-112.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Staines-Upon-Thames, Surrey

Forecasts